BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28434367)

  • 1. A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.
    Matsumoto S; Ueda M; Yamashita T; Amano T; Misumi Y; Tasaki M; Masuda T; Mizukami M; Furuya H; Ando Y
    Amyloid; 2017 Mar; 24(sup1):97-98. PubMed ID: 28434367
    [No Abstract]   [Full Text] [Related]  

  • 2. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
    Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348
    [No Abstract]   [Full Text] [Related]  

  • 3. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review.
    Yin J; Xia X; Shi Y; Lu Y; Zhao C; Huang Z; Tian N
    Amyloid; 2014 Jun; 21(2):140-2. PubMed ID: 24601824
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
    Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
    Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
    [No Abstract]   [Full Text] [Related]  

  • 7. First report of a rare mutation in a Polish patient with painful late-onset transthyretin amyloidosis.
    Hagenacker T; Brenck J; Kastrup O
    J Neurol Sci; 2014 Nov; 346(1-2):331-2. PubMed ID: 25130926
    [No Abstract]   [Full Text] [Related]  

  • 8. Transthyretin-related hereditary amyloidosis in an Argentinian family with TTR Tyr114Cys mutation.
    Aguirre MA; Nucifora EM; Rugiero M; Sorroche P; Saez MS; Giunta DH; Posadas-Martinez ML; Boietti BR
    Amyloid; 2017 Mar; 24(sup1):102. PubMed ID: 28434328
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation.
    Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.
    Koike H; Yasuda T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sobue G; Katsuno M
    Amyloid; 2018 Jun; 25(2):141-142. PubMed ID: 29855203
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.
    Masuda T; Ueda M; Misumi Y; Nomura T; Inoue Y; Isoguchi A; Kanenawa K; Tasaki M; Yamashita T; Sonoda Y; Obayashi K; Ando Y
    Amyloid; 2019; 26(sup1):79-80. PubMed ID: 31343297
    [No Abstract]   [Full Text] [Related]  

  • 12. Oculoleptomeningeal Amyloidosis Due to Transthyretin p.Y89H (Y69H) Variant.
    Quintanilha GS; Cruz MW; Silva MTT; Chimelli L
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1134-1136. PubMed ID: 32856080
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed diagnosis of transthyretin amyloidosis with a novel mutation (c.210T>A) in the transthyretin gene.
    Dekmezian MS; Tschen JA; Cho-Vega JH
    J Am Acad Dermatol; 2013 Feb; 68(2):e49-51. PubMed ID: 23317988
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
    Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M
    Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280
    [No Abstract]   [Full Text] [Related]  

  • 15. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
    Matsushima M; Yabe I; Tsuda M; Sakakibara M; Shimamura T; Sasaki H
    Intern Med; 2017 Dec; 56(23):3231-3235. PubMed ID: 28943540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.
    Dixit N; Castano A; Farr MJ; Traub R; Lentzsch S; Brown RS; Maurer MS; Brannagan TH
    J Clin Neuromuscul Dis; 2016 Mar; 17(3):142-5. PubMed ID: 26905915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant.
    Nakano Y; Tadokoro K; Ohta Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Yamashita T; Ando Y; Abe K
    J Neurol Sci; 2018 Jul; 390():22-25. PubMed ID: 29801893
    [No Abstract]   [Full Text] [Related]  

  • 18. [Familial amyloid neuropathy associated with the Cys114 mutation of the transthyretin gene in a Russian family].
    Strokov IA; Diukova GM; Pogromov AP; Generozov EV; Zhadin PM; Kovalchuk MO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):67-72. PubMed ID: 18688962
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid detection of wild-type and mutated transthyretins.
    Tasaki M; Ueda M; Obayashi K; Motokawa H; Kinoshita Y; Suenaga G; Yanagisawa A; Toyoshima R; Misumi Y; Masuda T; Yamashita T; Ando Y
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):508-10. PubMed ID: 26342004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study.
    Beck G; Yonenobu Y; Kawai M; Ikenaka K; Sera F; Ozono T; Shimada Y; Yamashita R; Sakata Y; Morii E; Yoshinaga T; Ando Y; Murayama S; Mochizuki H
    J Neurol; 2023 Sep; 270(9):4544-4548. PubMed ID: 37154892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.